Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.19 | 5e-08 |
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-06 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-06 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-06 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.13 | 1e-05 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |